Clinical trials are at the heart of medical advances. They are designed to test the safety and efficacy of new approaches to preventing, detecting, and treating disease. Trials also look for new ways to use existing treatments, new drugs, surgical procedures and devices.
Clinical trial participants enroll to possibly receive the newest treatment for their conditions, to have additional care and attention from clinical trial staff, and to help researchers find better treatments for future patients. In the United States, clinical trials must meet rigorous standards and be registered with the National Institutes of Health.
- Participation in a clinical trial is free of charge.
- FDA treatment for retinal disease is not available (dry AMD).
- Patient is sub-responder to currently approved FDA treatment.
- Clinical trials offer cutting-edge treatment options that are potentially better than standard of care.
- Contribute to clinical research advancement.
- Additional care and attention during study visits: ECG, blood work, frequent eye exams: bilateral for most protocols & performed non-protocol at certain visits if not part of protocol, fellow eye treatment is often provided by the sponsor, transportation to and from appointments, dedicated coordinator throughout the study, snacks, coffee, lunch for long study visits, stipend for each completed visit.